UnitedHealth Group Incorporated $UNH Shares Sold by Pin Oak Investment Advisors Inc.

Pin Oak Investment Advisors Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 65.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 342 shares of the healthcare conglomerate’s stock after selling 660 shares during the period. Pin Oak Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $107,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Semus Wealth Partners LLC grew its holdings in shares of UnitedHealth Group by 21.8% during the second quarter. Semus Wealth Partners LLC now owns 3,016 shares of the healthcare conglomerate’s stock valued at $941,000 after purchasing an additional 540 shares during the last quarter. Purus Wealth Management LLC boosted its position in UnitedHealth Group by 70.7% during the 2nd quarter. Purus Wealth Management LLC now owns 768 shares of the healthcare conglomerate’s stock valued at $240,000 after purchasing an additional 318 shares during the period. Inspire Advisors LLC increased its position in UnitedHealth Group by 12.1% in the second quarter. Inspire Advisors LLC now owns 1,840 shares of the healthcare conglomerate’s stock worth $574,000 after buying an additional 198 shares during the period. English Capital Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter valued at $2,446,000. Finally, Empowered Funds LLC increased its holdings in shares of UnitedHealth Group by 103.7% in the 2nd quarter. Empowered Funds LLC now owns 89,029 shares of the healthcare conglomerate’s stock worth $27,774,000 after acquiring an additional 45,320 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $320.59 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $622.83. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The company’s 50-day moving average price is $347.66 and its two-hundred day moving average price is $318.23. The stock has a market cap of $290.40 billion, a PE ratio of 16.73, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business’s revenue was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $7.15 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s payout ratio is presently 46.14%.

Analyst Ratings Changes

Several research firms have commented on UNH. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Robert W. Baird restated an “underperform” rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Royal Bank Of Canada increased their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. KeyCorp upped their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price on the stock. in a research note on Wednesday, October 29th. Eighteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.